IOL Chemicals and Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IOL Chemicals and Pharmaceuticals Limited generated cash of $2,900,800,000, which is more than the previous year. Cash used in financing activities reached the amount of -$925,000,000 last year. Net change in cash is therefore $63,000,000.
Cash Flow
| 2010 | 314.24M | -720.85M | 405.67M |
|---|---|---|---|
| 2011 | 236.43M | -693.30M | 590.23M |
| 2012 | 549.10M | -868.80M | 230.45M |
| 2016 | 176.99M | -252.66M | 92.68M |
| 2018 | 1.19B | -503.8M | -703.6M |
| 2020 | 4.71B | -1.84B | -2.71B |
| 2021 | 3.79B | -3.17B | -582.8M |
| 2023 | 1.22B | -1.2B | -41.1M |
| 2024 | 2.90B | -1.91B | -925M |
IOLCP.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 13.9M | 32.3M | 280.9M | 134.1M | 17.6M | 129.91M | 199.39M | 66.02M | 66.95M |
Operating activities | |||||||||
Net income | 1.34B | 1.88B | 5.71B | 5.33B | 313M | -385.50M | 47.53M | 61.79M | 100.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 629.1M | 461.6M | 389.2M | 357.3M | 302.1M | 296.86M | 239.36M | 237.62M | 100.11M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 276.6M | -430.7M | -295M | -503.6M | -346.6M | -631.86M | 0 | 0 | 0 |
Inventories | -993.2M | 843.7M | -1.07B | 13.4M | 551.7M | -145.19M | -321.90M | -326.90M | -145.29M |
Accounts payable | 1.61B | -1.04B | 606.1M | 518M | -173.8M | 485.17M | 0 | 0 | 0 |
Cash generated by operating activities | 2.90B | 1.22B | 3.79B | 4.71B | 1.19B | 176.99M | 549.10M | 236.43M | 314.24M |
Investing activities | |||||||||
Purchases Of Investments | -5.4M | -176.1M | -2.21B | -1.02B | 0 | -357.32K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.74B | -2.11B | -1.08B | -802.8M | -483.6M | -266.71M | -886.73M | -707.45M | -730.97M |
Acquisitions Net | 0 | 199.5M | 137.3M | 6M | 700K | 1.37M | 0 | 0 | 0 |
Cash generated by investing activities | -1.91B | -1.2B | -3.17B | -1.84B | -503.8M | -252.66M | -868.80M | -693.30M | -720.85M |
Financing activities | |||||||||
Common Stock Issued | 0 | 0 | 279.5M | 0 | 0 | 179.55M | 0 | 180M | 126M |
Payments for dividends | -293.5M | -235M | -234.8M | -205.7M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 280.4M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -468.7M | -10.9M | -559.9M | -2.28B | -248.1M | 217.77M | 0 | 0 | 0 |
Cash used in financing activities | -925M | -41.1M | -582.8M | -2.71B | -703.6M | 92.68M | 230.45M | 590.23M | 405.67M |
Net Change In Cash | 63M | -18.4M | 42.5M | 146.8M | -10.2M | 17.02M | -89.06M | 133.37M | -929.43K |
Cash at end of period | 76.9M | 13.9M | 323.4M | 280.9M | 7.4M | 146.93M | 110.32M | 199.39M | 66.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |